M T Lock, F H de Jong, D R Chadha, F H Schröder. Show Affiliations »
Abstract
Mesh: See more » Buserelin/pharmacologyBuserelin/therapeutic useHumansLuteinizing Hormone/bloodMaleProstatic Neoplasms/bloodProstatic Neoplasms/drug therapyTestosterone/blood
Substances: See more » TestosteroneLuteinizing HormoneBuserelin
Year: 1985 PMID: 2866306 DOI: 10.1016/s0140-6736(85)90758-5
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321